0
ARTICLE |

Preliminary Report: 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure to Humans—Seveso, Italy

JAMA. 1989;261(6):831-832. doi:10.1001/jama.1989.03420060031011.
Text Size: A A A
Published online

Extract

Kimbrough RD, ed. Halogenated biphenyls, terphenyls, naphthalenes, dibenzodioxins and related products . New York: Elsevier/ North-Holland Biomedical Press, 1980;:322-48.
Cerlesi S, Di Domenico A, Ratti S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) persistence in the Seveso (Milan, Italy) soil. Presented at Dioxin '88, Umea, Sweden, August 21-26,1988.
Mastroiacovo P, Spagnolo A, Marni E, Meazza L, Bertollini R, Segni G.  Birth defects in the Seveso area after TCDD contamination . JAMA 1988;;259:1668-72.
Mocarelli P, Marocchi A, Brambilla P, Gerthoux P, Young DS, Mantel N.  Clinical laboratory manifestations of exposure to dioxin in children: a six-year study of the effects of an environmental disaster near Seveso, Italy . JAMA 1986;;256:2687-95.
Caramaschi F, Del Corno G, Favaretti C, Giambelluca SE, Montesarchio E, Fara GM.  Chloracne following environmental contamination by TCDD in Seveso, Italy . Int J Epidemiol 1981;;10:135-43.
Pocchiari F, Silano V, Zampieri A.  Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy . Ann NY Acad Sci 1979;;320:311-20.
Facchetti S, Fornari A, Montagna M.  Distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the tissues of a person exposed to the toxic cloud at Seveso . Forensic Environ Appl 1981;;1:1406-44.
Patterson DG Jr, Hampton L, Lapeza CR Jr, et al.  High-resolution gas chromatographic/high-resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin . Anal Chem 1987;; 59:2000-5.
Patterson DG Jr, Needham LL, Pirkle JL, et al.  Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from Missouri . Arch Environ Contam Toxicol 1988;;17:139-43.
 CDC Veterans Health Studies. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in US Army Vietnam-era veterans . JAMA 1988;;260:1249-54.
CDC.  Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in Air Force Health Study participants—preliminary report . MMWR 1988;;37:309-11.
Fingerhut M, Sweeney M, Patterson D, Marlow D, Hornung R, Halperin W. Levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the serum of U.S. chemical workers exposed to dioxin-contaminated products. Presented at Dioxin '88, Umea, Sweden, August 21-26,1988.
Beck H, Eckart K, Mathar W, Ruhl C-S, Wittkowski R. Levels of PCDDs and PCDFs in adipose tissue of occupationally exposed workers. Presented at Dioxin '87, Las Vegas, Nevada, October 4-9, 1987.
Pirkle JL, Wolfe WH, Patterson DG Jr, et al.  Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Ranch Hand Veterans . J Environ Health Toxicol (in press).
Zone R was originally thought to be a reference zone, but on subsequent detection of TCDD concentrations in soil, Zone S was added.
Levels of TCDD in serum or adipose tissue of the general population are less than 20 ppt.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs